User profiles for "author:María Alonso de Leciñana"

María Alonso de Leciñana

Servicio de Neurología. Centro de Ictus. Hospital Universitario La Paz
Verified email at salud.madrid.org
Cited by 4265

Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID-19 stroke registry

G Ntaios, P Michel, G Georgiopoulos, Y Guo, W Li… - Stroke, 2020 - Am Heart Assoc
Recent case-series of small size implied a pathophysiological association between
coronavirus disease 2019 (COVID-19) and severe large-vessel acute ischemic stroke. Given …

Cerebral ischemia: from animal studies to clinical practice. Should the methods be reviewed?

MA de Leciñana, E Díez-Tejedor, F Carceller… - Cerebrovascular …, 2001 - karger.com
The development of experimental models of focal cerebral ischemia has allowed for a better
knowledge of its pathophysiology and for testing therapeutic strategies. However, most …

Final results of allogeneic adipose tissue–derived mesenchymal stem cells in acute ischemic stroke (AMASCIS): A phase II, randomized, double-blind, placebo …

E de Celis-Ruiz, B Fuentes… - Cell …, 2022 - journals.sagepub.com
Acute ischemic stroke is currently a major cause of disability despite improvement in
recanalization therapies. Stem cells represent a promising innovative strategy focused on …

Stroke acute management and outcomes during the COVID-19 outbreak: a cohort study from the Madrid stroke network

B Fuentes, M Alonso de Leciñana, S García-Madrona… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: The coronavirus disease 2019 (COVID-19) outbreak has added
challenges to providing quality acute stroke care due to the reallocation of stroke resources …

Futile interhospital transfer for endovascular treatment in acute ischemic stroke: the Madrid stroke network experience

B Fuentes, M Alonso de Leciñana, A Ximénez-Carrillo… - Stroke, 2015 - Am Heart Assoc
Background and Purpose—The complexity of endovascular revascularization treatment
(ERT) in acute ischemic stroke and the small number of patients eligible for treatment justify …

[HTML][HTML] Brain and immune system-derived extracellular vesicles mediate regulation of complement system, extracellular matrix remodeling, brain repair and antigen …

GT Iglesias, M Fernández-Fournier, L Botella… - Brain, Behavior, and …, 2023 - Elsevier
Background Multiple sclerosis (MS) is an immune-mediated central nervous system disease
whose course is unpredictable. Finding biomarkers that help to better comprehend the …

Estrogens as neuroprotectants against ischemic stroke

M Alonso de Leciñana, JA Egido - Cerebrovascular Diseases, 2006 - karger.com
Estrogens have proven vasoprotective properties against atherosclerosis that depend on the
direct effect on vascular smooth muscle and endothelium and on systemic actions that imply …

[HTML][HTML] Circulating extracellular vesicles promote recovery in a preclinical model of intracerebral hemorrhage

F Laso-García, L Casado-Fernández, D Piniella… - … Therapy-Nucleic Acids, 2023 - cell.com
Circulating extracellular vesicles (EVs) are proposed to participate in enhancing pathways of
recovery after stroke through paracrine signaling. To verify this hypothesis in a proof-of …

Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors

I Corral, C Quereda, A Moreno, MJ Pérez-Elías… - Cerebrovascular …, 2009 - karger.com
Background: Stroke risk is increased in AIDS patients, and highly active antiretroviral
therapy (HAART) may accelerate atherosclerosis, but little is known about the incidence and …

Safety and outcome of revascularization treatment in patients with acute ischemic stroke and COVID-19: the global COVID-19 stroke registry

JP Marto, D Strambo, G Ntaios, TN Nguyen, R Herzig… - Neurology, 2023 - AAN Enterprises
Background and Objectives COVID-19–related inflammation, endothelial dysfunction, and
coagulopathy may increase the bleeding risk and lower the efficacy of revascularization …